{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-005916","form_type":"8-K","ticker":"OGEN","cik":"0001174940","company_name":"ORAGENICS INC","filed_at":"2024-02-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:23.565469+00:00","generated_at":"2026-06-06T04:09:40.185021+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oragenics CEO Kimberly Murphy departs; Pope named Exec Chairman, Redmond Interim PEO","bullets":["CEO Kimberly Murphy separated from company Feb 12, 2024, per mutual agreement; remains on board of directors.","Charlie Pope appointed Executive Chairman, Michael Redmond named Interim Principal Executive Officer immediately.","Separation provides benefits under employment agreement for termination without cause; no disagreement cited."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-005916","json":"https://secwatch.observer/filing/0001493152-24-005916.json","markdown":"https://secwatch.observer/filing/0001493152-24-005916.md","text":"https://secwatch.observer/filing/0001493152-24-005916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T04:09:40.185021+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39797d8c55","claim":"Michael Redmond was appointed as Interim Principal Executive Officer at ORAGENICS INC.","evidence_excerpt":"In addition, effective February 12, 2024, the Board appointed Michael Redmond, the Company’s President, as the Company’s Interim Principal Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Interim Principal Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"3f05c609b9","claim":"Charlie Pope was appointed as Executive Chairman at ORAGENICS INC.","evidence_excerpt":"The Board will provide direction to the Company during this transition in management, with Charlie Pope, the Company’s Chairman of the Board, serving, on an interim basis, as Executive Chairman, effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Chairman"}],"fact_type":"executive_change"},{"claim_id":"42f9fe290e","claim":"Kimberly Murphy was terminated as Chief Executive Officer at ORAGENICS INC.","evidence_excerpt":"On February 12, 2024, Oragenics, Inc. (the “Company”) and Kimberly Murphy, the Company’s Chief Executive Officer, entered into a mutually agreeable Separation Agreement (the “Separation Agreement”), pursuant to which Ms. Murphy’s employment with the Company terminated effective February 12, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1174940/000149315224005916/0001493152-24-005916-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"terminated"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}